Skip to main content

Advertisement

Table 2 Antiestrogenic and antiproliferative activity of compound 9

From: Estrogen alpha receptor antagonists for the treatment of breast cancer: a review

Compound No. (IC50 = µM)
Antiestrogenic activity Antiproliferative activity (MCF-7)
9 0.050 0.022
Fulvestrant 0.003 0.004